đź“‹ FDA Reference

Vascular Occlusion System Trufill Pushable Coils and Trufill Dcs Orbit Detachable Coil Sysem

Codman & Shurtleff

Product: Trufill Dcs Orbit — all models and sizes

Compare similar devices

Summary: The TruFill Pushable Coils and TruFill DCS Orbit Detachable Coil System are used for vascular occlusion in embolization procedures. They are typically used by interventional radiologists and neurosurgeons.

FDA Clearance Information

Pathway ? 510(k)
Number ? K123560 ↗
Decision Date ? January 25, 2013
Product Code ? HCG Device, Neurovascular Embolization
Device Class ? Class 2
Evidence ? 9 studies

The TruFill Coils were cleared through the FDA 510(k) pathway on January 25, 2013, by Codman & Shurtleff. They are classified as Class 2 medical devices.

What It Is

The TruFill Pushable Coils and TruFill DCS Orbit Detachable Coil System are medical devices designed for vascular occlusion. These coils are used to block blood flow in targeted blood vessels, aiding in the treatment of aneurysms or other vascular abnormalities. The pushable coils are manually advanced into the vessel, while the detachable system allows for precise placement and release of the coil.

FDA-Cleared Indications

  • Embolization procedures requiring occlusion of selected blood vessels.
  • Endovascular treatment in which a coil is used to reduce or stop blood flow in a targeted vessel.

Clinical Applications

  • Coil embolization of a targeted blood vessel during an endovascular procedure.
  • Occlusion of selected vessels associated with vascular abnormalities when the treating physician determines that coil embolization is appropriate.
  • Use of pushable coils for manually delivered vascular occlusion.
  • Use of detachable coils for controlled placement and release through a compatible microcatheter.

Reported off-label uses

  • Treatment of selected cerebral aneurysms or vascular malformations when the specific device labeling does not identify that condition as an indication.
  • Embolization of selected peripheral or visceral vessels outside the device's cleared labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The operator selects coil diameter, length and configuration based on the target vessel, blood-flow pattern and desired degree of occlusion.
  • The coils are delivered through a compatible catheter or microcatheter; detachable coils permit position confirmation before release, while pushable coils are advanced into place and cannot be retrieved after deployment in the same way.
  • The procedure is performed with fluoroscopic or angiographic imaging, usually through catheter access in the groin or wrist, depending on the treatment site.
  • MRI safety and conditional-use requirements depend on the exact coil model, implanted configuration and current manufacturer labeling. The device identification and implant documentation should be reviewed before MRI.
  • Potential risks include unintended vessel occlusion, coil migration, vessel injury, bleeding at the access site, infection, thromboembolism and recurrence or incomplete occlusion. Contraindications and warnings in the device instructions must be reviewed before use.

Linked Studies (9)

PubMed • 2026

Middle Meningeal Artery Embolization with n-Butyl Cyanoacrylate for the Treatment of Subdural Hematomas: The MEMBRANE Study Design.

Stroke (Hoboken, N.J.)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Comparison of Cost and Efficacy of Trufill® vs Histoacryl® n-Butyl Cyanoacrylate for Translumbar Type 2 Endoleak Embolization.

Vascular and endovascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2014

ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.

Journal of neurointerventional surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2013

Complex shaped detachable platinum coil system for the treatment of cerebral aneurysms: the Codman Trufill DCS and Trufill DCS Orbit Detachable Coil System COMPLEX Registry final results.

Journal of neurointerventional surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2012

Initial Clinical Experience with a New Complex-Shaped Detachable Platinum Coil System for the Treatment of Intracranial Cerebral Aneurysms. The Cordis Trufill DCS Detachable Coil System.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2008

Midterm clinical experience with a complex-shaped detachable platinum coil system for the treatment of cerebral aneurysms: Trufill DCS Orbit detachable coil system registry interim results.

Journal of vascular and interventional radiology : JVIR

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2007

Combined use of TruFill DCS detachable coil system and Guglielmi detachable coil for embolization of meningioma fed by branches of the cavernous internal carotid artery.

Neurologia medico-chirurgica

View Source →
PubMed • 2002

N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.

AJNR. American journal of neuroradiology

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

View Source →

Frequently Asked Questions

What is TruFill Coils used for?

TruFill Coils are used for vascular occlusion in embolization procedures, particularly to treat aneurysms and vascular malformations.

What specialties typically use this device?

Interventional radiologists and neurosurgeons typically use these devices in endovascular procedures.

What are the FDA-cleared indications?

The devices are indicated for use in embolization procedures to occlude blood vessels, particularly in the treatment of aneurysms and vascular malformations.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you